FN1 and colorectal carcinoma: Fn promotes CRC progression through virulence factors such as FadA and Fap2, activating the host oncogenic pathway (e.g., WNT/β-catenin), disrupting epithelial integrity, and enabling immune evasion through TIGIT inhibition [13].